« Return to News | Miscellaneous

Encorium Appoints New CEO, Replaces Borow

Monday, February 25, 2008 11:05 AM

Wayne, Pa.-based Encorium Group has appointed Kai Lindevall, M.D., Ph.D., as chief executive officer, replacing president and CEO, Kenneth Borow, M.D.

Borow, who ran the company for seven years, will assume the role of chief medical officer and strategic development officer.

Lindevall was Encorium’s president of operations for the company’s Europe and Asia business. He was the founder and former CEO of Remedium Oy, and joined Encorium when it acquired that company in November 2006. The company stated it made the changes to allow Borow to focus on expanding its consultancy business and international business development.

"In my position as CEO I shall oversee the implementation of the strategy that our entire senior management team anticipates will lead to success in terms of predictable growth and improved financial results.  With Ken now able to focus more of his time on building our consultancy services and delivering on new business development opportunities, the team should be well positioned to achieve our targets for global growth and profitability,"stated Lindevall.

Encorium also stated it plans to expand into the emerging markets of China, India, and Latin America.

"Expansion into new therapeutic and geographic areas through both organic growth and acquisitions will be essential in achieving our strategic targets. My expertise bringing CRO services into emerging markets will be very helpful in accomplishing our goals," said Lindevall.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.